RAPT Therapeutics Inc (RAPT)
1.565
-0.14
(-8.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.565
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Price to Book Value: 0.5002 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2024 | 0.5465 |
| November 11, 2024 | 0.5592 |
| November 08, 2024 | 0.9236 |
| November 07, 2024 | 0.9907 |
| November 06, 2024 | 0.8692 |
| November 05, 2024 | 0.7829 |
| November 04, 2024 | 0.7254 |
| November 01, 2024 | 0.7126 |
| October 31, 2024 | 0.6775 |
| October 30, 2024 | 0.7031 |
| October 29, 2024 | 0.6391 |
| October 28, 2024 | 0.6168 |
| October 25, 2024 | 0.604 |
| October 24, 2024 | 0.5656 |
| October 23, 2024 | 0.5497 |
| October 22, 2024 | 0.572 |
| October 21, 2024 | 0.5257 |
| October 18, 2024 | 0.572 |
| October 17, 2024 | 0.5401 |
| October 16, 2024 | 0.5592 |
| October 15, 2024 | 0.5784 |
| October 14, 2024 | 0.6168 |
| October 11, 2024 | 0.5816 |
| October 10, 2024 | 0.5337 |
| October 09, 2024 | 0.5976 |
| Date | Value |
|---|---|
| October 08, 2024 | 0.6008 |
| October 07, 2024 | 0.6008 |
| October 04, 2024 | 0.6391 |
| October 03, 2024 | 0.6359 |
| October 02, 2024 | 0.719 |
| October 01, 2024 | 0.5912 |
| September 30, 2024 | 0.6423 |
| September 27, 2024 | 0.6264 |
| September 26, 2024 | 0.5976 |
| September 25, 2024 | 0.5624 |
| September 24, 2024 | 0.5624 |
| September 23, 2024 | 0.5624 |
| September 20, 2024 | 0.572 |
| September 19, 2024 | 0.6168 |
| September 18, 2024 | 0.5816 |
| September 17, 2024 | 0.6072 |
| September 16, 2024 | 0.6008 |
| September 13, 2024 | 0.6232 |
| September 12, 2024 | 0.6168 |
| September 11, 2024 | 0.6168 |
| September 10, 2024 | 0.6359 |
| September 09, 2024 | 0.6423 |
| September 06, 2024 | 0.5848 |
| September 05, 2024 | 0.6168 |
| September 04, 2024 | 0.6519 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5002
Minimum
Nov 13 2024
14.59
Maximum
Jan 27 2020
4.012
Average
3.704
Median
Oct 28 2022
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.346 |
| Arbutus Biopharma Corp | 6.488 |
| GlycoMimetics Inc | 1.282 |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 0.7477 |
Price to Book Value Related Metrics
| PS Ratio | 18.57 |
| PEG Ratio | -0.1056 |
| Price | 1.565 |
| Earnings Yield | -200.0% |
| Market Cap | 54.62M |
| PEGY Ratio | -0.1056 |